Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd is a Canada-based medical device company. The Company is engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It is developing a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, imaging, and cardiotoxicity in... see more

TSXV:VPT - Post Discussion

VentriPoint Diagnostics Ltd > Conference call
View:
Post by Stanny1 on Apr 03, 2024 3:49pm

Conference call

I just listened to the call replay.  Seemed like some good questions by investors but not very many answers. I'm not knowledgeable enough about this industry to comment on his responses and strategies.  Happy to hear these are reducing attending conferences.  I didn't really gain any confidence from what I heard.  Sounds like they have always lacked a sales strategy.  Makes you wonder whats been going on the last few years. Wondering what others felt.  ( and I have the bully on ignore so I won't have to read his bs)
Comment by WalkOverTheStrt on Apr 03, 2024 11:29pm
I've personally spoken to Hugh (3 weeks ago) and came away impressed.   He in 6 weeks has ramped up incredibly quickly and accomplished some decent early wins/steps. I believe he has the right vision and sales-brand- marketing strategy to get sales ramped. I wasn't impressed with GA or Alvira if that gives any context. I expect 2024 to slowly proceed with some potential wild cards to ...more  
Comment by G1945V on Apr 04, 2024 10:21am
Isn't  Hugh an interim CEO? G1945V
Comment by jopatclo on Apr 04, 2024 10:40am
This post has been removed in accordance with Community Policy
Comment by Pandora on Apr 04, 2024 4:49pm
Toronto, Ontario – February 13, 2024 - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV:VPT)(OTCVPTDF) announces changes to the Board of Directors. With the recent appointment of Hugh MacNaught as Interim CEO and President, the composition of board committees has been adjusted as follows:. Nominating and Corporate Governance Committee: Dr. George Adams ...more  
Comment by WalkOverTheStrt on Apr 04, 2024 6:10pm
I was told they are not interviewing for a few. Please confirm with IR but I am under the impression Hugh has the helm for the near and medium fiture. I get the sense many of the things needed he can enact and lead.  
Comment by Pandora on Apr 05, 2024 6:13pm
From what I can see Ascend is a private company. Maybe at some point they will buy out VPT to become a publicly listed company.
Comment by WalkOverTheStrt on Apr 08, 2024 5:20pm
Ascend seems relatively small (38 employees on LinkedIn) so I wouldn't expect them to have the capital or raise enough to get there. Just an opinion but if we want Ventripoint to get to a $250m - 500m market cap we will need a large player like Phillips or GE HC or a PE firm to come in. VMS is an attractive bolt on candidate as it's basically the IP play with a small workforce. 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities